The former president of the African Union, HE Dr Jean Ping recently met with HH Sheikh Faisal bin Saqr Al Qasimi, Chairman of Julphar, Dr Ayman Sahli, Julphar CEO and the Julphar executive team to discuss opportunities for expansion throughout East Africa with the launch of Julphar Ethiopia – its newest manufacturing facility.
Located in the Gerji Jakros region of the Ethiopian capital Addis Ababa, the 40,000 square foot facility will produce solid dosage and liquid dosage forms of medicines. Julphar is working closely with international regulatory bodies to gain WHO Approval, ISO Accreditation and CGMP compliance.
The capacities of this facility will allow production of 150 million bottles per year of suspension and syrup, 500 million tablets per year and 170 million capsules per year. 150 local employees from Ethiopia are required for the initial phase of launching the facility.
According to the IMF, today’s Ethiopia has one of the fastest growing economies in the world. This dynamic country is rich in culture and resources. After investing heavily in infrastructure over the past five years, it has experienced major growth. Julphar aims to contribute to the rapid development of Ethiopia with the launch of Julphar Ethiopia.
Julphar has been operating in Ethiopia for eight years now and its products can be found in major hospitals, clinics and retail pharmacies throughout East Africa.
Julphar has a major presence in Africa, with staff throughout East Africa in Ethiopia, Kenya, Tunisia, Sudan and Uganda.
Julphar Ethiopia is planning to launch in Q1 of 2013.